Just over half of multitarget stool DNA tests ordered are completed, with age and race influencing compliance as well as positivity rates.

A Seattle-based plastic surgeon ran afoul of federal law when his practice requested that patients sign an agreement aimed at limiting negative online reviews.

Easing out-of-pocket expenses for preventive medications for peripheral arterial disease could help improve adherence and health outcomes.

Novo Nordisk said on Friday its experimental next-generation obesity drug CagriSema helped overweight patients cut their weight by 22.7% in a late-stage trial, below the 25%...

Treatment-resistant depression complicates care, defying standard treatments, but new therapies are on the horizon, offering hope for more effective treatment options.

Milestone Pharmaceuticals said on Friday the U.S. health regulator had declined to approve its nasal spray to treat a type of heart condition and had called for an...

Although urate-lowering drugs form the cornerstone of gout therapy, there are only three oral medications currently available in the United States, and all have significant limitations.

Individuals with a higher adherence to the Mediterranean diet may have a slightly reduced risk for certain obesity-related cancers, a recent analysis found.

The FDA has granted marketing authorization to CT-132, an adjunctive, prescription digital therapeutic for the preventive treatment of episodic migraine.

Antipsychotics are the best defense against relapse in schizophrenia. But which ones offer the greatest benefit with the least cost to cognitive function?

The new guide aimed to educate compounding pharmacists and reassure prescribers about the ethical, legal, and practical considerations that must be addressed to ensure quality standards.

Children on higher-dose tuberculosis treatment regimens, as per 2010 World Health Organization guidelines, experience more adverse events than those on lower-dose regimens.

The U.S. Food and Drug Administration has updated its infant formula compliance program for investigators, laboratory analysts and compliance

The process of refilling prescriptions post-discharge continues to pose challenges for patients with opioid use disorder discharged from the emergency department, promoting their return to opioid use.

The US Food and Drug Administration has approved the first-ever prescription app for major depressive disorder.

Erenumab was more effective than oral preventive medications in reducing migraine days with better patient adherence and satisfaction.

Experts have expressed concerns that disruptions to treatment will allow the bacteria to further mutate to new, untreatable forms.

Relative to fecal immunochemical testing, the multitarget stool RNA test ColoSense showed a significant improvement in sensitivity for colorectal cancer and advanced adenomas.

Results from a study in Sweden show the potential of using artificial intelligence in mammography.

A new study aimed to examine associations between dietary patterns and survival among Black women diagnosed with epithelial ovarian cancer.